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Type 1 diabetes (T1D) is an autoimmune disease that shows familial aggregation in humans and likely has 
genetic determinants. Disease linkage studies have revealed many susceptibility loci for T1D in mice and 
humans. The mouse T1D susceptibility locus insulin-dependent diabetes susceptibility 3 (Idd3), which has a 
homologous genetic interval in humans, encodes cytokine genes Il2 and Il21 and regulates diabetes and other 
autoimmune diseases; however, the cellular and molecular mechanisms of this regulation are still being elu-
cidated. Here we show that T cells from NOD mice produce more Il21 and less Il2 and exhibit enhanced Th17 
cell generation compared with T cells from NOD.Idd3 congenic mice, which carry the protective Idd3 allele 
from a diabetes-resistant mouse strain. Further, APCs from NOD and NOD.Idd3 mice played a central role in 
this differential Th17 cell development, and IL-21 signaling in APCs was pivotal to this process. Specifically, 
NOD-derived APCs showed increased production of pro-Th17 mediators and dysregulation of the retinoic 
acid (RA) signaling pathway compared with APCs from NOD.Idd3 and NOD.Il21r-deficient mice. These data 
suggest that the protective effect of the Idd3 locus is due, in part, to differential RA signaling in APCs and that 
IL-21 likely plays a role in this process. Thus, we believe APCs provide a new candidate for therapeutic inter-
vention in autoimmune diseases.
*OUSPEVDUJPO
Type 1 diabetes (T1D) is an autoimmune disease that shows famil-
ial aggregation in humans and appears to be, at least partially, 
genetically determined. The NOD mouse serves as a good model 
for human diabetes, because the disease appears spontaneously and 
bears pathogenic features remarkably similar to those of human 
T1D. Genetic analyses of T1D in NOD mice and in humans have 
identified many susceptibility loci. One of these loci, insulin-depen-
dent diabetes susceptibility 3 (Idd3), encodes several genes, of which 
only the cytokine genes Il2 and Il21 currently have known immu-
nological importance. NOD mice carrying the Idd3 locus from dia-
betes-resistant C57BL/6 mice (NOD.Idd3 mice) are protected from 
autoimmune diabetes and EAE (1, 2). In this genetic interval, Il2 
and Il21 are inherited as a haplotype. IL-2 and IL-21 are both T cell–
derived cytokines that have antagonistic effects on the development 
of Foxp3+ Tregs and proinflammatory Th17 cells. IL-2 promotes 
Treg differentiation, whereas IL-21 suppresses it; in contrast, IL-21 
supports the generation of Th17 cells, while IL-2 constrains Th17 
differentiation (3–7). Thus, the Idd3 genetic interval may regulate 
the balance between pathogenic Th17 and protective Foxp3+ Tregs 
through the differential effects of IL-2 and/or IL-21.
Indeed, some studies suggest that the protective effect of the Idd3 
genetic interval is due to increased production of Il2, which enhanc-
es Treg function, in NOD.Idd3 congenic mice (8). In this regard, 
we and others reported that the defective Treg function observed 
in NOD mice, relative to that of NOD.Idd3 mice, is determined by 
differences in NOD-derived versus NOD.Idd3-derived APCs (9, 10), 
rather than by intrinsic defects in the Tregs from NOD mice.
Although the role of IL-2 in the protective effect of Idd3 has 
received much attention, considerable evidence supports a role for 
IL-21 as well. It has been reported that IL-21 expression is elevated 
in NOD mice compared with that in diabetes-resistant strains of 
mice and that increased IL-21 expression is the key to susceptibil-
ity to autoimmune disease (11). In support of this, Il21 receptor–
deficient (Il21r-deficient) NOD mice were reported to be protected 
against autoimmune diabetes (12–14).
The recently characterized Th17 cells have been shown to be 
highly pathogenic, and it has been argued that this subset is the 
primary mediator of tissue inflammation in many autoimmune 
diseases (15). The involvement of Th17 cells in diabetes is not well 
understood, but there is a growing body of research implicating 
Th17 cells in its pathogenesis (16–18). Using either neutraliz-
ing anti–IL-17 mAb or recombinant IL-25, Th17 cells have been 
demonstrated to have a pivotal role in T1D. The Th17-blocking 
therapies prevented diabetes development in NOD mice with a 
concomitant reduction in islet-specific T cell responses (19).
Here we show that T cells derived from NOD mice have a greater 
propensity to differentiate into Th17 cells compared with T cells 
from both NOD.Idd3 mice and NOD.Il21r KO mice. We further 
show that, in additional to intrinsic T cell differences, APCs have 
an important role in determining the balance of regulatory and 
pathogenic T cells. NOD- and NOD.Idd3-derived APCs differen-
tially support Th17 cell polarization, and this difference in APC 
Conflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article: J Clin Invest. 2011;121(11):4303–4310. doi:10.1172/JCI46187.
Downloaded from http://www.jci.org on January 13, 2015.   http://dx.doi.org/10.1172/JCI46187
SFTFBSDIBSUJDMF
 The Journal of Clinical Investigation   http://www.jci.org   Volume 121   Number 11   November 2011
function is associated with retinoic acid (RA) signaling that may 
be regulated by IL-21. In the study of autoimmunity, APCs have 
received little attention relative to T cells. Our data suggest that 
APCs are key players and represent other avenues for therapeutic 
intervention in autoimmune diseases.
3FTVMUT
NOD-derived cells have a greater potential to generate Th17 cells than 
NOD.Idd3-derived cells. To compare the expression of Il21 and Il2 
in naive T cells from NOD and NOD.Idd3 congenic mice, real-
time PCR was performed. We found that T cells from NOD mice 
expressed more Il21 and fewer Il2 transcripts than NOD.Idd3-
derived T cells upon in vitro activation using anti-CD3 plus anti-
CD28 (Supplemental Figure 1A; supplemental material available 
online with this article; doi:10.1172/JCI46187DS1). Accordingly, 
when naive T cells were activated in the presence of self APCs, IL-21 
and IL-17 production was elevated in NOD cultures compared 
with that in NOD.Idd3 cultures (Supplemental Figure 1B). Since 
recent data show that IL-2 and IL-21 have pivotal and opposing 
roles in the development of Th17 cells, we compared the gener-
ation of Th17 cells in vitro using naive T cells from NOD and 
NOD.Idd3 mice. In the absence of APCs, the polarization of Th17 
cells, using a combination of IL-6 and TGF-β in NOD cultures, 
was on average twice as efficient as that in NOD.Idd3 cultures, as 
indicated by a higher frequency of IL-17+ T cells (Figure 1A). This 
defect is in line with the increased Il21 and decreased Il2 expression 
by T cells from NOD mice compared with that from NOD.Idd3 
mice (Supplemental Figure 1). Furthermore, Th17 polarization 
was enhanced in both NOD and NOD.Idd3 cultures when neu-
tralizing anti–IL-2 mAb was added. However, even at the highest 
dose of anti–IL-2 used, NOD.Idd3-derived T cells remained less 
efficient in polarizing to Th17 cells than NOD-derived T cells 
(Supplemental Figure 2). Thus, differential expression of IL-2 
alone cannot account for the reduced potential of NOD.Idd3 T 
cells to differentiate into Th17 cells.
Since we and others previously showed that APCs from NOD 
and congenic NOD.Idd3 mice have important effects on the sup-
pressive activity of Tregs (9, 10) and that Tregs and Th17 cells 
have a reciprocal relationship (20), we examined the relative con-
tribution of NOD- versus NOD.Idd3-derived APCs on Th17 cell 
differentiation. By swapping APCs, we found that NOD-derived 
APCs were more efficient at supporting the differentiation of 
Th17 cells, irrespective of the source of T cells (Figure 1B), while 
NOD.Idd3-derived APCs could not support polarization of Th17 
cells as efficiently as NOD-derived APCs. Moreover, APCs from 
NOD.Idd3 mice enhanced production of IFN-γ, a prototypical 
cytokine of Th1 cells, even in the presence of Th17-polarizing 
cytokines IL-6 and TGF-β (Figure 1B). This increased production 
of IFN-γ in the presence of NOD.Idd3-derived APCs was coinci-
dent with reduced IL-17 production. This raises the possibility 
that IFN-γ induced by and/or produced by NOD.Idd3 APCs was 
responsible for inhibiting Th17 polarization. Indeed, the addition 
of neutralizing anti–IFN-γ mAb improved Th17 differentiation in 
all conditions and almost completely abolished the differences in 
Th17 differentiation observed between APCs derived from NOD 
and NOD.Idd3 mice (Figure 1B). This is consistent with previ-
ous reports that IFN-γ inhibits Th17 cell generation (16, 21, 22). 
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Together, these data suggest that there is an APC-driven — as well 
as a T cell–intrinsic — difference in Th17 cell development between 
NOD and NOD.Idd3 mice. APCs from NOD.Idd3 congenic mice 
not only impaired Th17 differentiation but also promoted IFN-γ 
production by T cells, even under Th17 polarization conditions, 
thereby further inhibiting Th17 differentiation.
Th17 cells accumulate in NOD mice and can induce diabetes upon adop-
tive transfer. Given that NOD.Idd3 mice are protected from T1D 
and that both IL-2 and IL-21 can modulate the development of 
induced Tregs and Th17 cells, we assessed the balance of regu-
latory and pathogenic T cells in these mice. We and others have 
previously shown that the frequency of Tregs is not significantly 
different between NOD and diabetes-resistant NOD.Idd3 mice 
(8, 9, 23, 24). However, in prediabetic mice, we found that the ratio 
of Tregs/Th17 cells was higher in NOD.Idd3 mice than in NOD 
mice in both the splenic and pancreatic draining LN compart-
ments (Figure 2). We also looked at the development of Th1 cells 
by staining for IFN-γ. Treg/Th1 ratios in the pancreatic LNs of 
4- to 6-week-old mice were also higher in NOD.Idd3 congenic mice 
than those in NOD mice, but there was no difference in older mice 
or in the splenic compartment (Figure 2). These data indicate that 
the balance of Tregs/T effector cells is shifted toward effector cells, 
particularly Th17 cells, in NOD mice.
Th17 cells have become recognized as key orchestrators of many 
autoimmune disease processes (15), and indeed, NOD mice have 
higher frequencies of IL-17+ CD4 T cells in the pancreatic LNs as 
they progress toward diabetes (data not shown and ref. 17). Using 
T cells from mice with a TCR that is reactive to an islet antigen 
(BDC2.5 Tg mice), we thus directly compared the pathogenic capac-
ity of Th1 and Th17 cells to induce T1D upon adoptive transfer. 
Upon transfer into either lymphopenic NOD/SCID mice or intact 
NOD mice, islet-specific Th1 and Th17 cells, generated in vitro, 
were equally efficient at inducing diabetes (Supplemental Figure 
3A and ref. 18). Previous studies suggest that the diabetogenic 
effects of Th17 cells are due to and rely on the conversion of Th17 
cells into IFN-γ–producing Th1 cells in vivo (17, 18). To address 
this issue, we generated islet-specific Th17 cells from IFN-γ– 
deficient mice and demonstrated that they were just as efficient as 
IFN-γ+/+ Th17 cells at inducing T1D upon adoptive transfer into 
NOD mice (Supplemental Figure 3B). Thus, Th17 cells can induce 
T1D independently of IFN-γ.
IL-21 signaling both in T cells and APCs contributes to the defect in Th17 
cell generation and diabetes. Since the Idd3 locus regulates expression 
of both Il2 and Il21, and perturbation of IL21R signaling completely 
protected NOD mice from autoimmune diabetes (12–14), we inves-
tigated the effects of IL-21 signaling on Th17 cell development 
using NOD.Il21r KO mice. In line with previous reports using Il21- 
and Il21r-deficient mice on diabetes-resistant backgrounds (5–7), 
Il21r-deficient T cells from NOD mice exhibited a defect in gener-
ating Th17 cells (Figure 3A), similar to that of NOD.Idd3-derived 
T cells (Figure 1A). Given our observations that IL-21 production 
is reduced in NOD.Idd3 mice and that NOD.Idd3-derived APCs do 
not promote Th17 differentiation, we next investigated the abil-
ity of NOD.Il21r KO APCs to support Th17 differentiation. Like 
NOD.Idd3-derived APCs, NOD.Il21r KO APCs did not support Th17 
differentiation as well as NOD-derived APCs (Figure 3B). Further-
more, APCs from Il21r-deficient NOD.Idd3 mice (NOD.Idd3.Il21r 
KO mice) were even less efficient than NOD.Idd3-derived APCs at 
supporting Th17 generation (Figure 3B). These data show, for the 
first time to our knowledge, that IL-21 signaling in APCs conditions 
them for optimal Th17 generation. Moreover, these data support 
the hypothesis that decreased IL-21 signaling in APCs may partly 
underlie the disease resistance in NOD.Idd3 mice.
It is of interest that APCs from mice with either reduced IL-21 
signaling (NOD.Idd3 mice) or complete loss of IL-21 signaling 
(NOD.Il21r KO mice) were not able to support Th17 genera-
tion as well as APCs derived from NOD mice. Moreover, when 
NOD-derived T cells were activated under neutral conditions, 
they produced more IFN-γ when cocultured with APCs from 
NOD.Idd3 or NOD.Il21r KO mice than with APCs from NOD 
mice (Figure 3C). Together with the observation that NOD.Idd3-
derived APCs could promote IFN-γ production by T cells, even 
in the presence of Th17-polarizing cytokines, and that neutral-
ization of IFN-γ resulted in enhanced generation of Th17 cells 
'JHVSF
5IFEFGFDUJO5IDFMMHFOFSBUJPO
JO/0%*MS,0NJDFJTCPUI5DFMM
JOUSJOTJDBOE"1$ESJWFO	"
/BJWF
5DFMMTGSPN/0%PS/0%*MS,0
NJDF XFSF BDUJWBUFE XJUI QMBUF
CPVOE BOUJ$% BOE 	# BOE$

OBJWF5DFMMTGSPN/0%NJDFXFSF
BDUJWBUFEXJUITPMVCMFBOUJ$% JO
UIFQSFTFODF"1$T	"BOE#
JOUIF
QSFTFODFPS	$
BCTFODFPG*-BOE
5('β *OUSBDFMMVMBS TUBJOJOHXBT
QFSGPSNFEBGUFSEBZT7BMVFT JO
FBDIRVBESBOUPSHBUFSFQSFTFOUUIF
QFSDFOUBHFPG ""%m$% DFMMT
	$
 $FMMDPOEJUJPOFENFEJB XFSF
BTTFTTFEGPS*'/γQSPEVDUJPOBGUFS
IPVST%BUBBSFSFQSFTFOUBUJWFPG
UPJOEFQFOEFOUFYQFSJNFOUT
Downloaded from http://www.jci.org on January 13, 2015.   http://dx.doi.org/10.1172/JCI46187
SFTFBSDIBSUJDMF
 The Journal of Clinical Investigation   http://www.jci.org   Volume 121   Number 11   November 2011
(Figure 1B), these data indicate that APCs from NOD.Idd3 and 
NOD.Il21r KO mice both suppress IL-17 production by T cells, 
partly by promoting IFN-γ production.
NOD- and NOD.Idd3-derived CD11b+ cells differentially regulate 
Th17 polarization. Previously, we showed that the differential 
suppressive activity of Tregs from NOD and NOD.Idd3 mice 
was regulated by a subset of APCs expressing CD11b and lack-
ing the pan DC marker, CD11c (9). To identify the APC subsets 
associated with the differential Th17 cell polarization observed 
between NOD and NOD.Idd3 mice (Figure 1B), cocultures using 
APCs depleted of different subsets were set up. Upon depletion 
of CD11c–CD11b+ cells, the capacity of APCs from NOD and 
NOD.Idd3 mice to support Th17 polarization was equivalent 
(Figure 4A). Furthermore, the generation of Th17 cells was mark-
edly more efficient when CD11b+ cells were depleted, indicating 
that this APC subset from NOD and NOD.Idd3 mice may also 
differentially constrain Th17 differentiation. In contrast, when 
CD11c+ cells were depleted from the APC pool, Th17 polarization 
in the presence of NOD.Idd3-derived APCs remained suboptimal 
compared with that in the presence of NOD-derived APCs, and 
the absence of CD11c+ APCs did not affect the Th17 polarization 
efficiency in either culture (Figure 4A). Thus, these data suggest 
that, similar to the regulation of Treg function (9), CD11b+ cells, 
but not CD11c+ cells, contribute to the APC-driven defect in Th17 
cell development in NOD.Idd3 mice.
Thus, we compared CD11b+ APCs from NOD and NOD.Idd3 
mice as well as NOD.Il21r KO mice for differences that could affect 
Th17 differentiation. As prostaglandin E2 (PGE2), a proinflamma-
tory mediator, has been implicated in the development of Th17 
cells (25–27), we examined the production of both IL-6 and PGE2 
by CD11b+ APCs. Upon stimulation with a ligand for TLR2, pep-
tidoglycan (PGN), CD11b+ cells from NOD mice produced more 
PGE2 and IL-6 than cells from both NOD.Idd3 and NOD.Il21r 
KO mice (Figure 4B). Reduced production of PGE2 and IL-6 in 
NOD.Idd3-derived and NOD.Il21r KO CD11b+ cells does not 
reflect overall dampened responsiveness to stimulation, as TNF 
production was comparable in all 3 strains (Figure 4B).
Given that PGE2 and IL-6 are known pro-Th17 mediators, 
decreased production of these mediators by NOD.Idd3-derived and 
NOD.Il21r KO APCs is in line with a defect in Th17 cell generation 
regulated by APCs in these mice. In support of our hypothesis that 
IL-21 influences mediator production by CD11b+ APCs in NOD 
and NOD.Idd3 mice and that the difference in mediator produc-
tion is not caused by differential Il21r expression, we found that 
Il21r mRNA was similarly expressed on CD11b+ cells ex vivo from 
both strains (Supplemental Figure 4A). On the other hand, Il2ra 
expression was undetectable in CD11b+ cells ex vivo (Supplemental 
Figure 4A). Taken together, these data suggest that the differences 
in IL-21 signaling between NOD and NOD.Idd3 mice can influ-
ence the repertoire of proinflammatory mediators produced by 
APCs, which, in turn, affect Treg and Th17 cell generation and/or 
function. Thus, CD11b+ APCs may be differentially conditioned 
in diabetes-susceptible and diabetes-resistant mouse strains, and 
the observed differences in PGE2 and IL-6 production are merely 
products of greater underlying differences.
Gene profiling of CD11b+ cells reveals a link between altered RA signal-
ing in APCs and Th17 differentiation. To further explore the effect 
mediated by the Idd3 locus on CD11b+ cells, we compared the gene 
profiles of NOD- and NOD.Idd3-derived CD11b+ cells using whole 
genome microarray analysis (GEO accession GSE24350). Com-
parisons between CD11b+ cells isolated from NOD and NOD.Idd3 
mice yielded 213 and 335 transcripts with consistently more than 
2-fold differential expression in duplicate comparisons of unstim-
ulated and PGN-activated cells, respectively (Figure 5A).
Ingenuity Pathways Analysis software was used to highlight 
transcriptional networks of genes differentially expressed 
between NOD- and NOD.Idd3-derived CD11b+ cells. Interest-
ingly, some genes differentially expressed after TLR2 ligation in 
NOD- and NOD.Idd3-derived CD11b+ cells have been reported to 
be downstream of RA signaling (Figure 5B). All-trans RA, a vita-
min A metabolite, has been reported to regulate the reciprocal 
relationship between Tregs and Th17 cells, whereby RA inhibits 
Th17 cell generation and enhances Treg induction (28). Previ-
ously, we showed that IFN regulatory factor 4 (IRF4), which is 
critical for Th17 cell generation (29, 30), is downregulated by RA 
(31). Microarray analysis showed that Irf4 expression in CD11b+ 
cells from NOD mice was higher than that in NOD.Idd3 mice, 
both in unstimulated and PGN-stimulated cells; this was con-
firmed by real-time PCR (Figure 5, A and C). In support of RA 
possibly modulating Irf4 expression in NOD and NOD.Idd3 
mice, transcripts of RA receptors were detected in both CD11b+ 
and T cells from these mice (Supplemental Figure 4B). Moreover, 
Irf4 expression was also higher in acutely activated T cells from 
NOD mice than in those from NOD.Idd3 mice (Supplemental 
Figure 4C). Together with relatively higher Irf4 expression in 
NOD-derived CD11b+ cells, this is consistent with increased RA 
signaling in NOD.Idd3 mice. In addition, we showed previously 
that RA inhibits Il23r expression in T cells (31). Indeed, while 
this probe was not included on the Affymetrix Mouse Genome 
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430 2.0 microarray, real-time PCR showed that T cells as well as 
CD11b+ cells from NOD mice expressed elevated levels of Il23r 
transcript compared with those in cells from NOD.Idd3 mice 
(Supplemental Figure 4D and Figure 5C).
Epoxide hydrolase 1 (EPHX1) is an enzyme that protects against 
oxidative stress; CXCR5 is a chemokine receptor; ficolin A (FCNA) 
is a lectin; and apelin receptor (APLNR) is a receptor for angioten-
sin. Genes encoding these proteins are reported to be regulated by 
RA (32–35) and were more highly expressed in NOD-derived than 
NOD.Idd3-derived CD11b+ cells, as determined by microarray and 
confirmed by real-time PCR (Figure 5, A and C). Interestingly, the 
expression of Irf4, Ephx1, Fcna, and Aplnr in NOD.Il21r KO CD11b+ 
cells showed a similar pattern to that observed in NOD.Idd3-derived 
CD11b+ cells (Figure 5D), suggesting a possible connection between 
the RA and IL-21 signaling pathways.
If differential RA signaling in NOD.Idd3- and NOD-derived 
APCs regulates Th17 differentiation, then increasing RA signal-
ing in NOD-derived APCs could dampen Th17 differentiation to 
levels similar to those in cultures with NOD.Idd3-derived APCs. We 
therefore pretreated APCs from NOD mice with RA prior to cocul-
ture with naive T cells. When NOD-derived APCs were pretreated 
with RA, their ability to support Th17 polarization was dampened 
to the level observed in cultures with untreated NOD.Idd3-derived 
APCs (Figure 6, A and B). Furthermore, pretreatment of APCs in 
vivo by injecting RA into mice reduced their capacity to support 
generation of Th17 cells (Figure 6C). Lymphopenic mice (NOD/
SCID) were used to avoid confounding effects resulting from 
stimulation of T cells with RA. Collectively, these data support the 
hypothesis that RA signaling is dysregulated in NOD mice relative 
to that of NOD.Idd3 mice and that this altered signaling acts on 
APCs to modulate Th17 differentiation in these 2 strains.
%JTDVTTJPO
Our data demonstrate that naive T cells from NOD mice exhibit a 
greater propensity to differentiate into Th17 cells than NOD.Idd3-
derived T cells and that the balance of Tregs/Th17 cells is tipped 
toward pathogenic Th17 cells in vivo in NOD mice carrying the 
diabetes-susceptible Idd3 allele. Moreover, we show that NOD- and 
NOD.Idd3-derived APCs, specifically, CD11c–CD11b+ cells, differ-
entially support Th17 differentiation, and this difference is likely 
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to be regulated by IL-21. Lastly, our data suggest that RA signaling 
may be dysregulated in NOD mice, relative to that in NOD.Idd3 
mice, and that this leads to altered function of APCs.
We showed previously that NOD-derived CD11b+ APCs inhibit 
Treg function (9). We now present data that show that this same 
APC population also promotes Th17 cell differentiation in NOD 
mice relative to that of NOD.Idd3 congenic mice. Indeed, we show 
for the first time to our knowledge that there is a defect in Th17 cell 
generation in NOD.Idd3 mice that is not only T cell intrinsic but 
also mediated by APCs. Interestingly, these defects are mirrored in 
APCs from NOD.Il21r KO mice, suggesting that IL-21 signaling, 
in part, modulates APC function. IL-21 may act on APCs to induce 
production of mediators that, in turn, feedback onto T cells to fur-
ther promote Th17 polarization. Indeed, PGE2 and IL-6, mediators 
that facilitate Th17 generation, are more highly produced by APCs 
from NOD mice relative to that produced by APCs from either 
NOD.Idd3 or NOD.Il21r KO mice upon activation. It is plausible 
that IL-21 signaling not only acts directly on T cells to induce Th17 
cell development and inhibit Tregs but also acts indirectly by con-
ditioning APCs to produce mediators that further amplify proin-
flammatory Th17 cell differentiation and suppress Treg function. 
For instance, IL-6 can inhibit Treg induction (20, 36) and induce 
further IL-21 production (7), completing a positive feedback loop 
to maintain high IL-21 expression in NOD mice and boosting the 
inherent proinflammatory bias. In addition, under our experimen-
tal conditions, the Th17 polarization supported by NOD-derived 
and NOD.Idd3-derived APCs could be equalized after neutraliza-
tion of IFN-γ, suggesting that IFN-γ is another possible mediator 
produced by APCs and/or induced in T cells by APCs to inhibit 
Th17 cell generation. This represents a mechanism by which APCs 
can skew T cell differentiation away from Th17 and ultimately pro-
tect mice from autoimmune disease in diabetes-resistant strains.
Gene profiling of CD11b+ APCs from NOD and NOD.Idd3 mice 
shows that expression of many genes differs, indicating that the Idd3 
locus either directly or indirectly affects the development and effec-
tor functions of CD11b+ cells. IRF4, a transcription factor essential 
for Th17 cell development (29), is downregulated in CD11b+ cells 
from NOD.Idd3 mice as well as NOD.Il21r KO mice, relative to that 
in cells from NOD mice. Given our recent data showing that RA 
inhibits Th17 cell development by inhibiting IL-6 signaling and 
downregulating Irf4 (31), it is conceivable that NOD.Idd3 mice have 
elevated RA signaling. In support of differential RA signaling in 
NOD and NOD.Idd3 mice, many genes reported to be regulated by 
RA signaling were differentially expressed by CD11b+ APCs from 
NOD and NOD.Idd3 mice. Since RA has been reported to tip the 
Treg/T effector cell balance toward regulatory cells (28, 31, 37), it 
is in line with NOD mice having a lower Treg/T effector ratio than 
NOD.Idd3 mice. This is also consistent with studies showing that 
RA treatment (38, 39) and vitamin A–rich diets (40) can inhibit the 
development of T1D. Moreover, RA and PGE2, an enhancer of Th17 
cell development, are reported to be mutually antagonistic, whereby 
PGE2 inhibits synthesis of RA and vice versa (41, 42).
Since IRF4 induces IL-6 (43), increased Irf4 in NOD mice is in 
line with elevated IL-6 protein production by CD11b+ cells and 
consequently Th17 cell generation in these mice. While Il6 mRNA 
was not found to be differentially expressed in stimulated NOD 
and NOD.Idd3-derived CD11b+ APCs in our microarray analyses, 
this may simply reflect the different kinetics of IL-6 protein and 
mRNA expression. Given that IL-6 induces IL-21 (7) and that IRF4 
is required for IL-21–dependent generation and amplification of 
Th17 populations (30), this represents a convergence of pathways 
that lead to enhanced Th17 cell development. Furthermore, similar 
expression patterns of genes downstream of RA signaling in CD11b+ 
cells from both NOD.Idd3 and NOD.Il21r KO mice suggest that 
IL-21 may affect RA signaling. Reduced capacity of RA-treated APCs 
from NOD mice to promote the generation of Th17 cells further 
supports a link between RA signaling and APC-driven modulation 
of Th17 cell development.
Earlier studies have implicated defective APCs in the development 
of autoimmune diabetes in NOD mice (44–46), but the molecular 
mechanisms responsible for the difference were not identified. 
Moreover, recent studies on T1D patients show a defect in APCs, in 
that they produce more IL-6 and IL-1 (47). This is consistent with 
APCs having an important role in T1D development by altering the 
balance of pathogenic Th17 cells and protective Tregs. We previously 
reported that the reduced suppressive capacity of Tregs from NOD 
mice was mediated by APCs (9, 10), and here we provide evidence 
that APCs are important regulators of proinflammatory Th17 cell 
development and that IL-21 signaling is pivotal to the T cell–APC 
cross-talk that modulates Th17 differentiation, which, in turn, 
determines susceptibility to autoimmunity. Most of the differences 
between NOD and NOD.Idd3 mice are recapitulated in NOD.Il21r 
KO mice, suggesting an important role for IL-21, in addition to IL-2, 
in mediating the protective effects attributed to Idd3.
Clearly, RA-regulated pathways do not exist in isolation, and 
much of what we know about RA and its effects has been studied 
in other cell types. Further studies are required to elucidate how 
RA signaling operates in APCs and how this differs between NOD 
and NOD.Idd3 mice. Furthermore, understanding how IL-21 sig-
'JHVSF
3"TJHOBMJOHJO"1$TEBNQFOT5IEJGGFSFOUJBUJPOJO/0%5DFMMT
/BJWF5DFMMTGSPN/0%NJDFXFSFTUJNVMBUFEXJUITPMVCMFBOUJ$%
QMVT5('βBOE*-JOUIFQSFTFODFPG"1$TUIBUXFSFQSFUSFBUFEXJUI
PSXJUIPVU3"	"
"GUFSEBZT5IQPMBSJ[BUJPOXBTBTTFTTFECZ
JOUSBDFMMVMBSTUBJOJOH7BMVFTJOFBDIRVBESBOUSFQSFTFOUUIFQFSDFOU
BHFPG""%m$%DFMMT4DBUUFSQMPUTBSFSFQSFTFOUBUJWFPGJOEF
QFOEFOUFYQFSJNFOUTBOETVNNBSJ[FEJO#UIFNFBOPGJOEFQFO
EFOUFYQFSJNFOUTBSFTIPXO	NFBO4&.
1	$
"1$TXFSF
QSFUSFBUFEXJUI3"JOWJWPJO/0%4$*%NJDF7BMVFTBSFSFQSFTFOUB
UJWFPGJOEFQFOEFOUFYQFSJNFOUT	NFBO4&.O
1
Downloaded from http://www.jci.org on January 13, 2015.   http://dx.doi.org/10.1172/JCI46187
SFTFBSDIBSUJDMF
 The Journal of Clinical Investigation   http://www.jci.org   Volume 121   Number 11   November 2011 
naling converges with the RA pathway to modulate APC function 
would uncover important avenues for regulating T cell responses 
and autoimmune diseases.
.FUIPET
Mice and reagents. Female NOD and NOD.Idd3 (line 1098) mice were 
purchased from Taconic Farms as required. NOD.Il21r mice were back-
crossed onto the NOD background using a speed congenic approach (13). 
NOD.Idd3.Il21r KO mice were generated by intercrossing NOD.Idd3 and 
NOD.Il21r KO mice. Foxp3.gfp knockin (KI) reporter mice were generated 
as previously described (20) and then backcrossed 12 times onto NOD and 
NOD.Idd3 backgrounds. All experiments were carried out in accordance 
with the guidelines of the Institutional Animal Care and Use Committee 
at Harvard Medical School.
Beads for MACS were purchased from Miltenyi Biotec. All flow cytom-
etry reagents were purchased from BioLegend, except CD3-APC-cy7 and 
7-amino-actinomycin D (7-AAD), which were from BD Bioscience. Puri-
fied functional grade mAbs were obtained from BioXCell. Recombinant 
cytokines were purchased from R&D Systems.
T cell activation. CD4+CD62Lhi44lo naive cells were purified from predia-
betic NOD and age-matched NOD.Idd3 or NOD.Il21r KO mice by cell sort-
ing using a FACSAria (BD Bioscience), after enrichment for CD4+ T cells 
by MACS. Naive T cells were activated with either 1 μg/ml plate-bound 
anti-CD3 (clone 145-2C11) and 2 μg/ml soluble anti-CD28 (clone PV-1) or 
with 1 μg/ml soluble anti-CD3 in the presence of self APCs irradiated with 
33 Gy. Cytokine production in cell culture supernatants was determined 
either by ELISA or Cytometric Bead Array according to the manufacturer’s 
instructions (BD Biosciences) after 48 hours.
Real-time PCR. Real-time PCR was performed on an ABI Systems 7500 
Fast TaqMan machine using specific TaqMan probe sets purchased from 
ABI Systems and cDNA synthesized using the iScript Kit (Bio-Rad). Tran-
script expression was normalized against β-actin.
Th17 cell polarization. Naive T cells were activated with anti-CD3 plus 3 ng/ml 
TGF-β and 30 ng/ml IL-6 with or without 20 μg/ml anti–IFN-γ (clone 
XMG1.2) in the presence of irradiated APCs. Unless otherwise stated, CD4-
depleted splenocytes were used as APCs; for some experiments, CD11c+ or 
CD11c–CD11b+ cells were further depleted by cell sorting. APCs were pre-
treated with RA in vivo by injecting 0.5 mg RA in corn oil or corn oil alone 
i.p. into NOD/SCID mice on alternate days over 6 days; unfractionated 
splenocytes were used as APCs. For in vitro RA experiments, APCs (T cell– 
depleted splenocytes) were first pretreated with or without 10 nM RA 
(Sigma-Aldrich) for 20 hours. Cells were then washed, irradiated, and cul-
tured with naive NOD-derived T cells under Th17-polarizing conditions. 
Polarized cells were analyzed by intracellular cytokine staining after 3 days.
Intracellular cytokine staining. Cells were stimulated for 4 hours with 50 ng/ml 
PMA and 1 μg/ml ionomycin (both from Sigma-Aldrich) in the presence 
of 1 μl/ml monensin (Golgi Stop, BD Bioscience). Cell surface staining 
was followed by fixation and permeabilization with Cytofix/Cytoperm 
(BD Bioscience) and washed with Perm/Wash (BD Bioscience), as per the 
manufacturer’s directions for intracellular cytokine staining. Samples were 
acquired on a LSRII (BD Bioscience), and data analysis was performed with 
FlowJo software (TreeStar).
CD11b+ APC cultures. CD11b+ cells were isolated from CD11c-depleted sple-
nocytes by positive selection using MACS. CD11c–CD11b+ cells were stimu-
lated with PGN, and supernatants were harvested after 48 hours and assayed 
for cytokine production by cytometric bead array and PGE2 production 
using a Singleplex Multibead Kit from Assay Designs, both in accordance 
with the manufacturer’s instructions. For transcript profiling, CD11b+ cells 
were isolated by positive selection using MACS, and then CD11c–CD11b+ 
cells were purified by flow cytometry. Purified cells were stimulated with or 
without PGN for 4 hours.
Microarray analysis. RNA was isolated using the RNeasy Mini Kit (Qiagen), 
including a genomic DNA elimination column, according to the manu-
facturer’s instructions. cRNA probes were synthesized from RNA isolated 
from 2 independent experiments, and each was hybridized to Affyme-
trix Mouse Genome 430 2.0 microarrays at the Partners Center for Per-
sonalized Genetic Medicine. Microarray data have been deposited at the 
Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE24350; accession number GSE24350). Analysis 
of microarray data was performed using GenePattern software (Broad 
Institute). Transcripts with a coefficient of variance of greater than 0.55 
for unstimulated cells and 0.7 for PGN-stimulated cells in the duplicate 
samples were excluded. Network analysis was performed using Ingenuity 
Pathways Analysis software (Ingenuity Systems Inc.).
Statistics. Statistical analysis was performed using unpaired, 2-tailed Stu-
dent t tests, 1-way ANOVA, or Dunnett’s multiple comparison test and 
compared with the NOD reference group (Figure 6B). P values of less than 
0.05 were considered statistically significant.
Study approval. The experimental methods were reviewed and approved by the 
Institutional Animal Care and Use Committee at Harvard Medical School.
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